Table 3 Severe complications of co-infected patients.

From: A meta-analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co-infection

No.

Authors, year

Hypotension/shock

Hyperparasitemia

Severe anemia

Acute renal failure

Metabolic acidosis

Respiratory distress

Severe anemia and respiratory distress

Hypoglycemia

Cerebral malaria

Impaired consciousness/convulsion

Impaired consciousness

Coma

Convulsion

Prostration

Bleeding

Black water fever

Jaundice

Fatal

1.

Addissie et al. (2007)21

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

2.

Amodu-Sanni et al. (2020)22

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

3.

Berg et al. (2014)2

NS

33

15

24

NS

25

NS

8

NS

9

NS

NS

NS

NS

13

NS

17

NS

4.

Berg et al. (2008)23

NS

NS

NS

6

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

2

1

5.

Berg et al. (2020)24

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

9

NS

NS

9

6.

Berkley et al. (2009)25

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

7.

Beyene et al. (2017)26

NS

NS

25

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

8.

Bronzan et al. (2007)27

NS

NS

28

NS

NS

NS

NS

NS

86

NS

NS

NS

NS

NS

NS

NS

NS

NS

9.

Chalwe et al. (2009)28

NS

6

5

NS

NS

NS

NS

11

NS

NS

15

NS

6

NS

NS

NS

3

NS

10.

Cohen et al. (2005)15

2

3

3

14

11

NS

NS

1

3

NS

NS

NS

NS

NS

NS

NS

NS

NS

11.

Davenport et al. (2010)29

NS

NS

14

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

12.

Grimwade et al. (2004)42

NS

NS

14

28

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

9

NS

13.

Hendriksen et al. (2012)30

6

33

18

NS

38

20

18

10

NS

NS

NS

89

74

31

NS

15

9

NS

14.

Huson et al. (2015)32

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

1

15.

Hochman et al. (2015)31

NS

NS

NS

NS

NS

NS

NS

NS

15

NS

NS

NS

NS

NS

NS

NS

NS

NS

16.

Imani et al. (2011)43

NS

NS

NS

NS

NS

NS

NS

NS

9

NS

NS

NS

NS

NS

NS

NS

NS

NS

17.

Jacques et al. (2019)33

NS

NS

86

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

18.

Joice et al. (2016)34

NS

NS

NS

NS

NS

NS

NS

NS

20

NS

NS

NS

NS

NS

NS

NS

NS

NS

19.

Kyeyune et al. (2014)44

NS

NS

26

NS

NS

NS

NS

NS

26

NS

NS

NS

NS

NS

NS

NS

NS

NS

20.

Mandala et al. (2018)35

NS

NS

5

NS

NS

NS

NS

NS

9

NS

NS

NS

NS

NS

NS

NS

NS

NS

21.

Mouala et al. (2008)36

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

22.

Munyenyembe et al. (2018)37

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

23.

Niyongabo et al. (1994)45

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

24.

Nkuo-Akenji et al. (2008)38

NS

102

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

25.

Otieno et al. (2006)46

NS

NS

15

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

26.

Sandie et al. (2019)39

NS

NS

1

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

27.

Saracino et al. (2012)40

NS

NS

29

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

28.

Tagoe DNA and Boachie (2012)41

NS

NS

6

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

29.

Tay et al. (2015)17

NS

NS

11

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

NS

 

Total complications (1171)

8

177

301

72

49

45

18

30

168

9

15

89

80

31

22

15

31

11

 

Percentage

0.68

15.1

25.7

6.15

4.18

3.84

1.54

2.56

14.35

0.77

1.28

7.60

6.83

2.65

1.88

1.28

2.65

0.94

  1. NS Not specified.